What is NDC 51167-290?

51167-290 is the product NDC for Casgevy (exagamglogene autotemcel), Exagamglogene autotemcel 13000000 1/mL injection, suspension, listed with the FDA by Vertex Pharmaceuticals Incorporated. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Casgevy (Exagamglogene autotemcel).

Vertex Pharmaceuticals Incorporated, NDC labeler code 51167. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Casgevy?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Casgevy NDC 51167-290 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51167-290Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51167-0290Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51167-290-09	51167029009	9 VIAL in 1 CARTON (51167-290-09) / 20 mL in 1 VIAL (51167-290-01)Marketed from Dec 8, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Casgevy
Generic name (nonproprietary): exagamglogene autotemcel
Active ingredients: Exagamglogene autotemcel — 13000000 1/mL
Dosage form: Injection, Suspension
Route: Intravenous
Labeler: Vertex Pharmaceuticals IncorporatedNDC labeler code 51167
Product type: Cellular therapy
Marketing category: BLA — Biologics License ApplicationApplication BLA 125787
Marketing start: Dec 8, 2023
Listing expires: Dec 31, 2027
Identifiers: Product ID 51167-290_680dd873-8717-41be-a143-2fc36acf07eaSPL ID 680dd873-8717-41be-a143-2fc36acf07eaSPL set ID 7c3e12ad-e2fe-4d3f-a630-ea7364d9e846RxCUI 2671671, 2671677UNII S53L777GM8

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451167029009 followed by a unit qualifier and the quantity

Package 51167-0290-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 7, 2026.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE CASGEVY is indicated for the treatment of patients aged 2 years and older with: sickle cell disease (SCD) with recurrent vaso-occlusive crises transfusion-dependent β - thalassemia (TDT) CASGEVY is an autologous genome edited hematopoietic stem cell-based gene therapy indicated for the treatment of patients aged 2 years and older with: sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs). ( 1 ) transfusion-dependent β-thalassemia (TDT). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51167-290

What is NDC 51167-290?: 51167-290 is the product NDC for Casgevy (exagamglogene autotemcel), Exagamglogene autotemcel 13000000 1/mL injection, suspension, listed with the FDA by Vertex Pharmaceuticals Incorporated. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Casgevy (Exagamglogene autotemcel).
What is the active ingredient?: Exagamglogene autotemcel.
Who is the labeler?: Vertex Pharmaceuticals Incorporated, NDC labeler code 51167. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Casgevy?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Casgevy (Exagamglogene autotemcel) NDC 51167-290